Pall partners Swiss training firm for continuous biomanufacturing
Pall Life Sciences will equip a training facility in Fribourg, Switzerland.with its continuous bioprocessing equipment.
Archives for November 15, 2017
J&J biospecific antibody deal could net Zymeworks up to $1.5bn
Janssen Biotech has selected Zymeworks’ Azymetric and Effect platforms to make bispecific antibody therapeutics.